• 1
    Remontet L, Esteve J, Bouvier AM et al. Cancer incidence and mortality in France over the period 1978–2000. Rev Epidemiol Sante Publique 2003; 51: 330
  • 2
    Fritsche HM, Burger M, Svatek RS et al. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol 2010; 57: 300309
  • 3
    Smith SC, Baras AS, Dancik G et al. A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment. Lancet Oncol 2011; 12: 137143
  • 4
    Mitra AP, Pagliarulo V, Yang D et al. Generation of a concise gene panel for outcome prediction in urinary bladder cancer. J Clin Oncol 2009; 27: 39293937
  • 5
    Williams PD, Cheon S, Havaleshko DM et al. Concordant gene expression signatures predict clinical outcomes of cancer patients undergoing systemic therapy. Cancer Res 2009; 69: 83028309
  • 6
    Pfister C, Roupret M, Wallerand H et al. Recommendations Onco-Urology 2010: urothelial tumors. Prog Urol 2010; 20 (Suppl. 4): S255274
  • 7
    Richard S, Amy L, Ming-Chung L, Michael N, Supriya M, Yingdong Z. Analysis of gene expression data using BRB-array tools. Cancer Inform 2007; 3: 1117
  • 8
    Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 2001; 98: 3136
  • 9
    Billerey C, Sibony M. So-called ‘superficial’ bladder tumors. Which classification in 2003? Part 1: papillary tumors. Ann Pathol 2003; 23: 2133
  • 10
    Chopin DK, Gattegno B. Superficial bladder tumors. Eur Urol 2002; 42: 533541
  • 11
    Kirkali Z, Chan T, Manoharan M et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005; 66: 434
  • 12
    Montironi R, Lopez-Beltran A. The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol 2005; 13: 143153
  • 13
    Seitz M, Zaak D, Knuchel-Clarke R, Stief C. Urinary bladder tumours. The new 2004 WHO classification. Urologe A 2005; 44: 10731086
  • 14
    Bol MG, Baak JP, Buhr-Wildhagen S et al. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder. J Urol 2003; 169: 12911294
  • 15
    Gonul II, Poyraz A, Unsal C, Acar C, Alkibay T. Comparison of 1998 WHO/ISUP and 1973 WHO classifications for interobserver variability in grading of papillary urothelial neoplasms of the bladder. Pathological evaluation of 258 cases. Urol Int 2007; 78: 338344
  • 16
    Lopez-Beltran A, Algaba F, Berney DM et al. Handling and reporting of transurethral resection specimens of the bladder in Europe: a web-based survey by the European Network of Uropathology (ENUP). Histopathology 2011; 58: 579585
  • 17
    May M, Brookman-Amissah S, Roigas J et al. Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications. Eur Urol 2010; 57: 850858
  • 18
    Sharkey FE, Sarosdy MF. The significance of central pathology review in clinical studies of transitional cell carcinoma in situ. J Urol 1997; 157: 6870
  • 19
    Tosoni I, Wagner U, Sauter G et al. Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer. BJU Int 2000; 85: 4853
  • 20
    van Rhijn BW, van Leenders GJ, Ooms BC et al. The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading. Eur Urol 2010; 57: 10521057
  • 21
    Aaboe M, Marcussen N, Jensen KM, Thykjaer T, Dyrskjot L, Orntoft TF. Gene expression profiling of noninvasive primary urothelial tumours using microarrays. Br J Cancer 2005; 93: 11821190
  • 22
    Blaveri E, Simko JP, Korkola JE et al. Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res 2005; 11: 40444055
  • 23
    Dyrskjot L, Thykjaer T, Kruhoffer M et al. Identifying distinct classes of bladder carcinoma using microarrays. Nat Genet 2003; 33: 9096
  • 24
    Kawakami K, Enokida H, Tachiwada T et al. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling. Oncol Rep 2006; 16: 521531
  • 25
    Mengual L, Burset M, Ars E et al. DNA microarray expression profiling of bladder cancer allows identification of noninvasive diagnostic markers. J Urol 2009; 182: 741748
  • 26
    Modlich O, Prisack HB, Pitschke G et al. Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles. Clin Cancer Res 2004; 10: 34103421
  • 27
    Orsola A, Trias I, Raventos CX et al. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients. Eur Urol 2005; 48: 231238
  • 28
    Smits G, Schaafsma E, Kiemeney L, Caris C, Debruyne F, Witjes JA. Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression. Urology 1998; 52: 10091013
  • 29
    Faivre d'Arcier B, Celhay O, Safsaf A et al. T1 bladder carcinoma: prognostic value of the muscularis mucosae invasion (T1a/T1b). A multicenter study by the French Urological Association (CCAFU). Prog Urol 2010; 20: 440449
  • 30
    Lauss M, Ringner M, Hoglund M. Prediction of stage, grade, and survival in bladder cancer using genome-wide expression data: a validation study. Clin Cancer Res 2010; 16: 44214433